Sandra P. D'Angelo, MD

Dr
Memorial Sloan Kettering Cancer Center
New York, New York, United States

I am medical oncologist at Memorial Sloan Kettering Cancer Center dedicated to developing immunotherapy for the management of sarcoma . I am specifically interested in understanding the efficacy of various immunotherapies and elucidating biomarkers predictive of response in patients with these rare tumors in partnerships with basic scientists, cooperative groups and industry. At MSK, I lead the sarcoma-specific translational research program in immunotherapy to systematically explore novel combination strategies with including, but not limited to checkpoint blockade and adoptive T-cell therapy.

Presentation(s):

• Session 2: Novel Targets and Smart Drug Delivery

  Thursday, November 13, 2025
  11:30 AM - 12:30 PM EST

  Disclosure information not submitted.

• Paper 12 - INTEGRATED EFFICACY AND SAFETY ANALYSIS OF LETETRESGENE AUTOLEUCEL, A T-CELL RECEPTOR T-CELL THERAPY, ACROSS CLINICAL TRIALS OF PATIENTS WITH SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.

• Paper 65 - ASSOCIATION OF CLINICO-PATHOLOGIC FEATURES AND MOLECULAR GENOTYPES WITH OUTCOMES OF SYSTEMIC THERAPY IN METASTATIC SOFT TISSUE LEIOMYOSARCOMA (LMS) PATIENTS

  Saturday, November 15, 2025
  9:00 AM - 10:30 AM EST

  Disclosure information not submitted.

• Paper 68 - HISTOLOGY AND LOCAL RECURRENCE IN PRIMARY SOFT TISSUE SARCOMA OF THE EXTREMITY TREATED WITH IMRT

  Saturday, November 15, 2025
  11:00 AM - 12:00 PM EST

  Disclosure information not submitted.